The relationship between birth weight leptin and bone mineral status in newborn infants

Mustafa Akcakus1, Selim Kurtoglu, Esad Koklu

  • 1Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Turkey. akcakus@erciyes.edu.tr

Neonatology
|March 9, 2007
PubMed

Insights

Leptin levels in newborns did not correlate with bone mineralization, despite differences in birth weight. This study suggests leptin may not be a major regulator of fetal bone development.

Area of Science:

  • Neonatal development
  • Endocrinology
  • Pediatric bone health

Background:

  • Leptin is linked to fat and bone mass in fetal development.
  • Umbilical venous leptin levels predict neonatal skeletal size and bone mineral density.

Purpose of the Study:

  • To examine the correlation between birth weight, bone mineralization, and leptin levels in newborns.
  • To assess the predictive value of anthropometrics and gender on bone mineral status.

Main Methods:

  • 100 term newborns were analyzed, categorized by birth weight: appropriate for gestational age (AGA), small for gestational age (SGA), and large for gestational age (LGA).
  • Umbilical cord venous blood samples were collected for leptin level measurement.
  • Whole body bone mineral density and content were assessed using dual-energy X-ray absorptiometry within 24 hours of birth.

Main Results:

  • Leptin concentrations were significantly higher in LGA and lower in SGA infants compared to AGA.
  • LGA infants exhibited higher whole body bone mineral density and content, while SGA infants showed lower values.
  • Regression analysis indicated no significant relationship between leptin levels and bone indices.

Conclusions:

  • The study found no evidence to support leptin's major role in regulating bone metabolism in the developing neonatal skeleton.
  • Findings suggest other factors may be more critical for bone development regulation in newborns.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...